Literature DB >> 11828366

Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations.

Isabelle Migeotte1, Jean-Denis Franssen, Stanislas Goriely, Fabienne Willems, Marc Parmentier.   

Abstract

Human chemokine receptor (HCR) is a putative chemokine receptor sharing high similarity with CCR1, CCR2, CCR3 and CCR5. Its gene is located within the main cluster of CC-chemokine receptor genes, in the 3p21 region of the human genome. We generated monoclonal antibodies directed at human HCR, and studied its distribution in human leukocyte populations and cell lines, and its regulation following maturation or activation of these populations. In peripheral blood leukocytes, HCR is expressed on CD4+ and CD8+ T lymphocytes, including most memory and part of naive cells, but is absent from B cells. Expression of HCR was enhanced following stimulation of T cells by OKT3 and IL-2. HCR is present on monocytes and macrophages. Monocyte-derived dendritic cells harbored HCR, and expression was enhanced following stimulation by lipopolysaccharides, poly (I:C), IFN-gamma or CD40L. Neutrophils strongly expressed HCR. A similar distribution was found in bone marrow,and HCR was also expressed in CD34+ precursors. Expression of HCR and its regulation were confirmed by real-time PCR. In a panel of human tissues, we found abundant HCR transcripts in thymus, spleen, lymph nodes and lung. This large distribution across leukocyte populations, and the up-regulation during DC maturation, represent a new profile among chemokine receptors. We speculate that HCR responds to inflammatory chemokines, and might be involved in the interaction between antigen presenting and T cells, and in hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828366     DOI: 10.1002/1521-4141(200202)32:2<494::AID-IMMU494>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

Authors:  Teizo Yoshimura; Joost J Oppenheim
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

2.  The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors:  Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

3.  The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis.

Authors:  Israa G Akram; Rania Georges; Thomas Hielscher; Hassan Adwan; Martin R Berger
Journal:  Tumour Biol       Date:  2015-09-18

4.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

5.  Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner.

Authors:  Tanja N Hartmann; Marion Leick; Susann Ewers; Andrea Diefenbacher; Ingrid Schraufstatter; Marek Honczarenko; Meike Burger
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

6.  Chemokine receptor-like 2 is involved in ischemic brain injury.

Authors:  Robert M Douglas; Alice H Chen; Alejandra Iniguez; Juan Wang; Zhengxing Fu; Frank L Powell; Gabriel G Haddad; Hang Yao
Journal:  J Exp Stroke Transl Med       Date:  2013-02-17

7.  High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.

Authors:  Teng Hou; Dongxia Liang; Dong Yang; Jiehua He; Yongwen Huang; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 8.  Atypical chemokine receptors.

Authors:  Maria Helena Ulvmar; Elin Hub; Antal Rot
Journal:  Exp Cell Res       Date:  2011-01-25       Impact factor: 3.905

9.  Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis.

Authors:  Brian A Zabel; Susumu Nakae; Luis Zúñiga; Ji-Yun Kim; Takao Ohyama; Carsten Alt; Junliang Pan; Hajime Suto; Dulce Soler; Samantha J Allen; Tracy M Handel; Chang Ho Song; Stephen J Galli; Eugene C Butcher
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.